
Karacoline
CAS No. 39089-30-0
Karacoline( —— )
Catalog No. M24354 CAS No. 39089-30-0
Karacolinem is a natural product, reduces degradation of the extracellular matrix (ECM) in intervertebral disc degeneration (IDD) via the NF-κB signaling pathway.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 340 | In Stock |
![]() ![]() |
10MG | 507 | In Stock |
![]() ![]() |
25MG | 799 | In Stock |
![]() ![]() |
50MG | 1107 | In Stock |
![]() ![]() |
100MG | 1503 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameKaracoline
-
NoteResearch use only, not for human use.
-
Brief DescriptionKaracolinem is a natural product, reduces degradation of the extracellular matrix (ECM) in intervertebral disc degeneration (IDD) via the NF-κB signaling pathway.
-
DescriptionKaracolinem is a natural product, reduces degradation of the extracellular matrix (ECM) in intervertebral disc degeneration (IDD) via the NF-κB signaling pathway.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number39089-30-0
-
Formula Weight377.52
-
Molecular FormulaC22H35NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (66.22 mM)
-
SMILESO[C@@H]1C23C4C([C@]5(O)[C@]6([H])[C@@]3([H])C[C@@]([C@@H](OC)C5)([H])[C@@H]6O)C[C@]2([H])[C@@](CN4CC)(C)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Feeding deterrents from Aconitum episcopale roots against the red flour beetle, Tribolium castaneum.J Agric Food Chem. 2011 Apr 27;59(8):3701-6.
molnova catalog



related products
-
Thonningianin A
Thonningianin A has antioxidant property, involves radical scavenging, anti-superoxide formation and metal chelation.
-
1-Isomangostin
1-Isomangostin has cytotoxic and anticomplementary activities.
-
14-Deoxy-1112-didehy...
14-Deoxy-1112-didehydroandrographolide has hypotensive anti-inflammatory anti-asthma and anti-cancer actions. It can inhibit NF-κB activation.